N-methyl-D-aspartate receptor (NMDAR) (NMDAR)

N-methyl-D-aspartate receptors (NMDARs) are a class of ionotropic glutamate receptors essential for excitatory signaling and synaptic plasticity in the central nervous system (StatPearls, 2023). They are unique among ligand-gated ion channels because their activation requires the simultaneous binding of glutamate and a co-agonist, such as glycine or D-serine, alongside the removal of a voltage-dependent magnesium block (UniProt, 2024). This characteristic allows NMDARs to function as coincidence detectors, facilitating the calcium influx necessary for long-term potentiation and long-term depression, which are the cellular foundations of learning and memory (NCBI, 2023). In disease states, NMDAR overactivation leads to excitotoxicity through excessive calcium entry, contributing to neuronal death in stroke and neurodegenerative diseases like Alzheimer's (PubMed, 2022). Conversely, NMDAR hypofunction is strongly linked to the cognitive and negative symptoms of schizophrenia and is a target for emerging rapid-acting antidepressants (Nature Reviews Neuroscience, 2021). Drugs targeting these receptors, such as memantine and ketamine, act primarily as uncompetitive or non-competitive antagonists to modulate aberrant signaling without completely abolishing physiological function (PubChem, 2024). Therapeutic development remains challenging due to the high risk of dissociative side effects and the potential for cognitive impairment when the receptor's normal function is overly suppressed (Mayo Clinic, 2023).

Other names

Glutamate ionotropic receptor NMDA typeNMDA receptorN-methyl-D-aspartate-sensitive glutamate receptorGRINGlutamate [NMDA] receptor

Uncompetitive pore-blocking antagonism, non-competitive allosteric inhibition, glycine-site antagonism, and glycine-site partial agonism (PubChem, 2024).